Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sesquiterpenes | 2 | 2018 | 77 | 1.41 | Why? |
| Follistatin-Related Proteins | 4 | 2018 | 18 | 1.19 | Why? |
| Bleomycin | 3 | 2018 | 195 | 1.01 | Why? |
| Pulmonary Fibrosis | 3 | 2021 | 1068 | 0.89 | Why? |
| Transforming Growth Factor beta1 | 3 | 2018 | 204 | 0.85 | Why? |
| Sesquiterpenes, Eudesmane | 1 | 2018 | 1 | 0.78 | Why? |
| Snail Family Transcription Factors | 1 | 2018 | 20 | 0.75 | Why? |
| Free Radical Scavengers | 1 | 2018 | 82 | 0.72 | Why? |
| Cellulose | 1 | 2018 | 106 | 0.72 | Why? |
| Lactones | 1 | 2018 | 62 | 0.71 | Why? |
| Nanofibers | 1 | 2018 | 143 | 0.66 | Why? |
| Delayed-Action Preparations | 1 | 2018 | 291 | 0.64 | Why? |
| Quercetin | 1 | 2018 | 297 | 0.59 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2018 | 595 | 0.44 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.43 | Why? |
| Patient Discharge | 2 | 2021 | 5696 | 0.36 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.35 | Why? |
| Drug Discovery | 1 | 2018 | 3092 | 0.27 | Why? |
| Lung | 7 | 2021 | 31049 | 0.27 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.26 | Why? |
| Flavonols | 1 | 2021 | 100 | 0.21 | Why? |
| Food Deprivation | 1 | 2018 | 4 | 0.19 | Why? |
| NIH 3T3 Cells | 1 | 2018 | 147 | 0.18 | Why? |
| Drug Liberation | 1 | 2018 | 141 | 0.18 | Why? |
| Endometrium | 1 | 2018 | 68 | 0.18 | Why? |
| Mice, Inbred ICR | 1 | 2018 | 242 | 0.18 | Why? |
| Antibiotics, Antineoplastic | 1 | 2018 | 128 | 0.17 | Why? |
| Solubility | 1 | 2018 | 382 | 0.17 | Why? |
| Silicosis | 1 | 2017 | 20 | 0.17 | Why? |
| Crosses, Genetic | 1 | 2016 | 13 | 0.17 | Why? |
| Bone Morphogenetic Protein 4 | 1 | 2016 | 6 | 0.17 | Why? |
| Fibroblasts | 2 | 2018 | 839 | 0.17 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 230 | 0.17 | Why? |
| Mice | 6 | 2021 | 21357 | 0.17 | Why? |
| Organogenesis | 1 | 2016 | 24 | 0.17 | Why? |
| Sheep | 1 | 2018 | 420 | 0.16 | Why? |
| Muscle, Smooth, Vascular | 1 | 2017 | 86 | 0.16 | Why? |
| Arginine | 1 | 2018 | 377 | 0.15 | Why? |
| Mice, Inbred C57BL | 4 | 2021 | 5542 | 0.14 | Why? |
| Fomites | 1 | 2021 | 709 | 0.14 | Why? |
| Wearable Electronic Devices | 1 | 2022 | 694 | 0.14 | Why? |
| Epithelium | 1 | 2016 | 330 | 0.13 | Why? |
| Respiratory Function Tests | 1 | 2021 | 1755 | 0.13 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.12 | Why? |
| Bronchoalveolar Lavage | 1 | 2016 | 603 | 0.12 | Why? |
| Mice, Transgenic | 2 | 2017 | 2739 | 0.12 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.12 | Why? |
| Structure-Activity Relationship | 1 | 2018 | 2219 | 0.11 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.11 | Why? |
| Alleles | 1 | 2016 | 1557 | 0.10 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 907 | 0.10 | Why? |
| High-Throughput Screening Assays | 1 | 2018 | 1783 | 0.10 | Why? |
| Animals | 8 | 2021 | 78931 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2019 | 1222 | 0.09 | Why? |
| Respiratory Mucosa | 1 | 2016 | 1522 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2019 | 1666 | 0.08 | Why? |
| Virus Shedding | 2 | 2020 | 5834 | 0.08 | Why? |
| Fibrosis | 2 | 2021 | 800 | 0.07 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.07 | Why? |
| Phenotype | 1 | 2016 | 4037 | 0.07 | Why? |
| China | 5 | 2021 | 50654 | 0.07 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Oxygen | 1 | 2016 | 3715 | 0.06 | Why? |
| Mortality | 1 | 2019 | 7132 | 0.06 | Why? |
| Hepatitis B, Chronic | 1 | 2008 | 616 | 0.06 | Why? |
| Hepatitis B virus | 1 | 2008 | 882 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.05 | Why? |
| Male | 9 | 2021 | 367725 | 0.05 | Why? |
| Follistatin | 1 | 2018 | 25 | 0.05 | Why? |
| DNA, Viral | 1 | 2008 | 2521 | 0.04 | Why? |
| Creatine Kinase | 1 | 2020 | 386 | 0.04 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.04 | Why? |
| Myofibroblasts | 1 | 2017 | 61 | 0.04 | Why? |
| Liver Cirrhosis | 1 | 2008 | 1810 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Silicon Dioxide | 1 | 2017 | 131 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.04 | Why? |
| Transforming Growth Factor beta | 1 | 2018 | 363 | 0.04 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2020 | 415 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.04 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Humans | 15 | 2022 | 930598 | 0.04 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Interferon-alpha | 1 | 2020 | 1442 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.03 | Why? |
| Asia | 1 | 2019 | 2399 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.03 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Environmental Exposure | 1 | 2021 | 1558 | 0.03 | Why? |
| Hospitalization | 4 | 2020 | 54280 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Viral Load | 1 | 2008 | 15850 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Chronic Disease | 1 | 2022 | 5139 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Artificial Intelligence | 1 | 2022 | 3543 | 0.02 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Child | 2 | 2020 | 70012 | 0.01 | Why? |
| Aged | 3 | 2020 | 215776 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
Li's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(198)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_